Longevity Science Foundation Pursuing 120+ Year Human Lifespan Launches In Switzerland
A consortium of biotech founders, clinicians, and leading longevity research institutions announced today the launch of the Longevity Science Foundation. The new Swiss foundation has committed to distributing more than $1 billion over the next ten years to research, institutions and projects advancing healthy human longevity and extending the healthy human lifespan to more than 120 years.
The Longevity Science Foundation will provide funding to promising longevity research institutions and groups around the world. The focus of the Foundation will be to select support projects in four major areas of healthy longevity medicine and tech – therapeutics, personalised medicine, AI, and predictive diagnostics. The Foundation is seeking to fund projects that can make a significant difference in people’s lives as soon as possible - even within five years.
One of the main focuses of the Foundation is in driving longevity medicine from theoretical concepts to real-world applications. The Foundation’s donations will support the transformation of scientific findings and deep technological advances into treatments and solutions that can be used in the clinic today. By identifying and funding the most promising and cutting-edge advances, the Foundation seeks to address one of the most pressing issues in the science and applicability of longevity medicine - radical inequality in accessing and understanding longevity-focused treatment. Significant funding gaps remain an obstacle to bringing longevity medicine out of the laboratory and into the real world.
"The symbiotic efforts of the Foundation are a splendid chance for the field of Longevity Medicine to argue its position as a novel, most progressive and crucial medical specialty, as well as to accelerate the bridging of the gap between the gerosciences and the clinic. This includes advancing a patient-centered and personalised approach. After all, we are all patients suffering from aging, and as such as we should all be engaged in finding a solution," said Evelyne Yehudit Bischof, chairman of the Visionary Board for the Longevity Science Foundation and renowned longevity physician at Human Longevity Inc.
“The Longevity Science Foundation enables the rapid acceleration of basic science of human longevity and its translation towards human trials and clinical practice. In 5 years, healthy longevity will not only exist as a lab-proven concept, but will become part of everyone’s life,” said Andrea B. Maier, member of the Visionary Board and co-director of the Centre for Healthy Longevity at the National University of Singapore.
“Age is the greatest risk factor for nearly every major cause of death and disability in developed nations. Therapeutically targeting biological aging is key to fulfilling the promise of 21-st century medicine, and the Foundation is poised to play a central role in making this a reality,” said Matt Kaeberlein, CEO of the American Aging Association and Professor at the University of Washington, where he leads several major initiatives including the NIH Nathan Shock Center of Excellence in the Basic Biology of Aging and the Healthy Aging and Longevity (HALO) Research Institute.
Alex Zhavoronkov, Visionary Board member and an expert in AI-powered drug discovery noted that “the Foundation has created a unique and transparent mechanism for boosting early longevity research worldwide and ensuring mass public participation in decision making. This approach finally allows us to speak about getting closer to the idea of mass adoption of longevity ideas and treatments.”
“This new Foundation comes at a particularly important time to support the rapidly growing field of aging research. We have more possible targets than we can follow. The Foundation will allow our field to initiate new lines of investigation in aging research and to pursue them all the way to the clinic with the ultimate goal of increasing healthspan and lifespan in humans,” said Eric Verdin, Visionary Board Member and CEO and President of the Buck Institute.
The Foundation will also empower people from all over the world to directly support the development of longevity research. All contributors to the foundation will receive voting rights as part of their donation and will be able to help decide which projects receive funding. All projects will be first pre-selected by the Foundation’s board and evaluated for their technical soundness and potential impact on human longevity. The Foundation will also research essential topics in longevity research and share findings with the public to enhance awareness of longevity care and available treatments.
About the Longevity Science Foundation
The Longevity Science Foundation is a Swiss non-profit organisation advancing human longevity by funding research and development of medical technologies to extend the healthy human lifespan to more than 120 years. The long-term mission of the Longevity Science Foundation is to help make longevity-focused care accessible to everyone, no matter their background, by bringing cutting-edge science on aging out of the laboratory and into the mainstream. To learn more, visit www.longevity.foundation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
+31 06 422 13615
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Total Telecom: Leveraging Technology Innovation for Building Energy Efficiency 5G Networks20.10.2021 09:00:00 CEST | Press release
Total Telecom attended Huawei’s Better World Summit (BWS) for Green ICT for Green development in Dubai in United Arab Emirates (UAE), found out that the ICT industry, which is a backbone of the modern-day global economy, must adopt green and energy-efficient practices and products and take the lead in correcting the course of the climate change crisis. Huawei is at the forefront to reduce our new carbon emissions and has taken several initiatives to bring down its own carbon emissions. "With our innovative products and solutions, we want to work with customers and industry partners to jointly define industry standards, and help operators better measure and manage their carbon reduction roadmaps," says Bob Cai, Chief Marketing Officer at Carrier Business Group, while opening the Summit. The company is not just taking measures to reduce its carbon emissions but is also pursuing innovations to make telecom networks more sustainable and energy-efficient. Cai further elaborated that the ICT
FourKites Expands its Market-Leading Ocean Visibility Platform with Industry-First Dynamic ETA ® for Ocean Shipping and New Tools to Manage Demurrage and Detention20.10.2021 08:30:00 CEST | Press release
FourKites®, the world’s leading real-time supply chain visibility platform, today introduced Dynamic ETA® for Ocean, a new AI-powered innovation as part of its Dynamic OceanSM offering. The new enhancement provides shippers, carriers and 3PLs with the market’s most accurate estimated times of arrival (ETAs) for 100% of their ocean shipments across all lanes worldwide. In addition, the company has rolled out new capabilities for monitoring and mitigating demurrage and detention risks. With these new enhancements, FourKites now provides the most advanced and robust solution on the market for real-time and predictive ocean visibility, exception management and cost controls. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211019006198/en/ FourKites Expands its Market-Leading Ocean Visibility Platform with Industry-First Dynamic ETA® for Ocean Shipping and New Tools to Manage Demurrage and Detention (Photo: Business Wire) These po
Evasc Neurovascular Announces the New eCLIPs Bifurcation Flow Diverter20.10.2021 07:00:00 CEST | Press release
Evasc Neurovascular is proud to announce the third generation of its eCLIPs™ device, the eCLIPs Bifurcation Flow Diverter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211019006102/en/ The third generation of Evasc's eCLIPs™ device, the eCLIPs Bifurcation Flow Diverter. The new device is classified as a flow diverter, with a leaf density of 35%, which is 60% higher than the existing eCLIPs devices. As a result, the new eCLIPs Bifurcation Flow Diverter does not require coiling and provides for the same unique neck bridging delivery. The new eCLIPs Bifurcation Flow Diverter can cover up to a 6mm neck length. The eCLIPs Bifurcation Flow Diverter also simplifies deployment with greatly reduced delivery times. “We’re excited to see the latest innovation in Evasc Neurovascular’s eCLIPs devices, which will lead to better outcomes for patients and remarkable device delivery time—usually within 10 minutes,” said Leif Sorensen, Neur
Breaking the Silence in Osteoporosis20.10.2021 07:00:00 CEST | Press release
A new international survey of 1,008 women with osteoporosis from six countries, launched on World Osteoporosis Day, reveals that while more than two-thirds (67%) of women over the age of 55 mostly understand what osteoporosis is and the potential negative impact of future fractures, 19% felt poorly informed at the time of the diagnosis.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211019005894/en/ The survey initiated by Theramex in cooperation with the International Osteoporosis Foundation (IOF), was conducted in Germany, France, Italy, Spain, Australia, and Brazil. It included 316 postmenopausal women over the age of 55 years and 315 premenopausal women (40-55 years) with osteoporosis (altogether 62% of the surveyed women). Of these women, osteoporosis was only diagnosed after a fracture in almost 60% of the cases. This survey highlights a gap in osteoporosis awareness, as one-fourth of the patients aged 55 years and ov
Rossum raises record $100 million Series A from General Catalyst to reinvent B2B document communication20.10.2021 06:00:00 CEST | Press release
Rossum, the artificial intelligence company that is re-inventing the way businesses send documents to each other, has raised $100m from one of the US’s best known funds, General Catalyst in what is Eastern Europe’s largest ever Series A. Previous investors, including LocalGlobe, Seedcamp, Miton and Elad Gil are participating, as Rossum looks to capitalise on surging corporate demand for automation in business processes. Having rapidly secured market leadership in document AI technology and become the go-to software for many of Europe’s biggest companies, Rossum is creating a universal document gateway designed to help the corporate world move faster and complete transactions in minutes not weeks. Rossum’s founders, three PhD students who dropped out of university to start the business, are automating the whole business communication stack with a view to making bureaucratic, costly and time-consuming document communication frictionless and paperless. Rossum has seen year-on-year growth
Deenova Keeps Trouncing its competitors in France’s Unit Dose Pharmacy Automation Market20.10.2021 06:00:00 CEST | Press release
Deenova announced today it continues its record-breaking market momentum started during Covid-19, by winning 2 mechatronic competitive public tenders this Summer for a total of 4 ACCED robotic medication solutions to be operated around the clock at Centre Hospitalier Sainte-Marie Rodez in Occitanie, and Hospital of St Die-des-Vosges near Strasburg. Loïc Bessin, Managing Director of Deenova in France stated: “When I joined Deenova 3 years ago, the company was a small unit dose specialty business only present in 2 of the Top 5 European markets, having had customers only in France and Italy. I am extremely proud that over the last year alone, we have grown to become the dominant force in the GDP Top 5 healthcare European mechatronics markets for unit-dose, by establishing close partnership with key customers.” Christophe Jaffuel, Deenova Chief Commercial Officer, stated: “After Deenova multi-million and multi-year recent entries into the two largest European GDP healthcare markets in Germ
Amedeo and AURA AERO Announce a Strategic Partnership Agreement and a Letter of Intent to Purchase 200 Electric Regional Aircraft (“ERA”)19.10.2021 19:21:00 CEST | Press release
AURA AERO has created a clean sheet design while integrating new technologies, as well as existing technologies such as fly by wire, and is driving digital efficiencies to build revolutionary momentum in creating an electrical aircraft. With its current prototype aircraft, INTEGRAL, AURA AERO is achieving design and production maturity at a fraction of the cost and will carry that to the commercially sized 19- seater, Electric Regional Aircraft named ‘ERA’. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211019006068/en/ “Amedeo are delighted to have signed an LOI for 200 Electric Regional Aircraft ‘ERA,’ that draws the commercial aviation industry closer to achieving its goal of net-zero by 2050. We are very pleased to be partnered with AURA AERO in leading such an important climate supporting initiative for the future. For Amedeo, sustainable aviation is more than aspirational and we are committed and focused on partnership